Curated News
By: NewsRamp Editorial Staff
April 23, 2026

Federal Marijuana Rescheduling Could Slash Cannabis Taxes

TLDR

  • Trulieve Cannabis Corp. gains tax advantages as marijuana reclassification from Schedule 1 to 3 reduces financial burdens.
  • Executive Order 14067 initiates rulemaking to reclassify marijuana from Schedule 1 to 3 under the Controlled Substances Act.
  • Federal reclassification of marijuana expands medical research access, improving patient care and advancing treatment options.
  • President Trump's executive order could save cannabis firms millions in taxes by allowing standard business deductions.

Impact - Why it Matters

This news matters because federal rescheduling of marijuana from Schedule 1 to Schedule 3 would allow cannabis businesses to deduct standard business expenses, slashing effective tax rates from up to 70% to normal corporate levels. For companies like Trulieve, this could mean millions in savings, improving profitability and enabling reinvestment. Investors should watch this development as it could trigger a wave of consolidation and growth in the legal cannabis market, making it a pivotal moment for the industry.

Summary

Last December, President Trump signed an Executive Order that could dramatically reshape the cannabis industry. The directive, titled “Increasing Medical Marijuana and Cannabidiol Research,” calls for marijuana to be reclassified from Schedule 1 to Schedule 3 under the Controlled Substances Act (CSA). This move would have significant implications for cannabis businesses, particularly in terms of taxation. Under Schedule 1, cannabis companies are subject to IRS Section 280E, which denies them standard business deductions, resulting in effective tax rates as high as 70%. Rescheduling to Schedule 3 would remove this burden, allowing cannabis firms to deduct ordinary business expenses and potentially lowering their tax rates to standard corporate levels.

For larger marijuana firms like Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the rulemaking process couldn’t have come at a better time. Trulieve, a leading multi-state operator, stands to benefit significantly from a more favorable tax environment. The reclassification would also open doors for increased research into marijuana's medical applications and could pave the way for broader acceptance of cannabis products. However, the process is not immediate; it requires formal rulemaking by federal agencies such as the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA), and could take months or even years to finalize.

CNW420, a daily feature by CannabisNewsWire (CNW), highlights this development as part of its mission to keep investors informed about the evolving cannabis sector. CNW420 releases an article each business day at 4:20 p.m. Eastern, covering regulatory changes and market movements. For those interested in the legalized cannabis industry, staying updated through sources like CNW420 is crucial. As the landscape shifts, investors and businesses alike should monitor these regulatory changes closely, as they could have a profound impact on the financial viability of cannabis operations. The full article can be accessed via the provided link to "Read More>>" on CNW's website.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Federal Marijuana Rescheduling Could Slash Cannabis Taxes

blockchain registration record for this content.